Literature DB >> 14596500

Radiotherapy and cancer care in Sweden.

Torgil R Möller1, Nina Einhorn, Christer Lindholm, Ulrik Ringborg, Hans Svensson.   

Abstract

A systematic assessment of radiotherapy for cancer was conducted by The Swedish Council on Technology Assessment in Health Care (SBU) in 2001. It included an overview of the organisation of radiotherapy and cancer care in Sweden and education of staff. It further included an update of cancer statistics for Sweden and an estimate of the need for radiotherapy resources by the year 2010. The following conclusions were drawn: Compared with a similar assessment in 1992, the number of departments of oncology at the county hospital level has increased by one, and one more department was scheduled to start radiotherapy during 2002. The speciality of oncology in Sweden includes all types of non-surgical cancer treatment, in contrast to the situation in most countries, where radiation oncology and medical oncology are independent specialities. Gynaecologic oncology is a unique speciality for Sweden. The number of new cancer cases increased by 13% between 1990 and 2000, and continues to increase by more than 1.0% per year. The projections of cancer incidence stated in the previous report were checked against observed data for the year 2000 and found to be an underestimation. To maintain the current capacity for radiotherapy in relation to number of new cancer cases by the year 2010, a total of 65 accelerators would be needed.

Entities:  

Mesh:

Year:  2003        PMID: 14596500     DOI: 10.1080/02841860310010817

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  5 in total

1.  Defining the elements for successful implementation of a small-city radiotherapy department.

Authors:  P S Craighead; P Dunscombe
Journal:  Curr Oncol       Date:  2011-06       Impact factor: 3.677

Review 2.  Image-guided radiotherapy: from current concept to future perspectives.

Authors:  David A Jaffray
Journal:  Nat Rev Clin Oncol       Date:  2012-11-20       Impact factor: 66.675

3.  Applying physical science techniques and CERN technology to an unsolved problem in radiation treatment for cancer: the multidisciplinary 'VoxTox' research programme.

Authors:  Neil G Burnet; Jessica E Scaife; Marina Romanchikova; Simon J Thomas; Amy M Bates; Emma Wong; David J Noble; Leila Ea Shelley; Simon J Bond; Julia R Forman; Andrew Cf Hoole; Gillian C Barnett; Frederic M Brochu; Michael Pd Simmons; Raj Jena; Karl Harrison; Ping Lin Yeap; Amelia Drew; Emma Silvester; Patrick Elwood; Hannah Pullen; Andrew Sultana; Shannon Yk Seah; Megan Z Wilson; Simon G Russell; Richard J Benson; Yvonne L Rimmer; Sarah J Jefferies; Nicolette Taku; Mark Gurnell; Andrew S Powlson; Carola-Bibiane Schönlieb; Xiaohao Cai; Michael Pf Sutcliffe; Michael A Parker
Journal:  CERN Ideasq J Exp Innov       Date:  2017-06

4.  SKI2162, an inhibitor of the TGF-β type I receptor (ALK5), inhibits radiation-induced fibrosis in mice.

Authors:  Jin-hong Park; Seung-Hee Ryu; Eun Kyung Choi; Seung Do Ahn; Euisun Park; Kyung-Chul Choi; Sang-wook Lee
Journal:  Oncotarget       Date:  2015-02-28

Review 5.  Abscopal effect of radiotherapy combined with immune checkpoint inhibitors.

Authors:  Yang Liu; Yinping Dong; Li Kong; Fang Shi; Hui Zhu; Jinming Yu
Journal:  J Hematol Oncol       Date:  2018-08-16       Impact factor: 17.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.